Technician Law | Medication Errors | Patient Safety Live 1 credit hour
LIVE WEBINAR: February 24, 2026 7:00 PM - 8:00 PM (Central Time)

Many medications entering today’s market are developed through the 505(b)(2) pathway, yet pharmacy teams may be unaware of how these products differ from brand or generic options—creating risks related to product selection, safety, and workflow. This course discusses the regulatory and clinical nuances of 505(b)(2)-approved medications, including how to identify them, how they appear within electronic medication-management systems (e.g., EHR), and why they create unique operational, safety, and reimbursement considerations. You will gain strategies to distinguish 505(b)(2) products, implement standardized processes to reduce medication-error risk, and anticipate financial and workflow challenges associated with their use.

Learning Objectives

Upon successful completion of this application-based CPE course, pharmacy technicians should be able to:
1. Compare key differences between 505(b)(2)-approved products, brand medications, and generics, including their regulatory pathways.
2. Identify methods to determine whether a medication is 505(b)(2)-approved and associated risks of incorrect product selection or dispensing.
3. Discuss standardized processes for incorporating 505(b)(2)-approved products into electronic medication-management systems (e.g., EHR).
4. Analyze opportunities to improve patient safety, reduce medication-error risks, and address operational challenges associated with 505(b)(2) medications.
5. Evaluate elements of a structured approach to managing 505(b)(2)-approved products that promote patient safety and address operational challenges in practice.

Faculty

Bonnie Kirschenbaum, BScPharm, MSHSPAL, FASHP, FCSHP

Consultant, columnist

Disclosures:

Bonnie Kirschenbaum has no relevant financial relationships with ineligible companies to disclose.

Course Details